Rip Proteins in Innate Immune Signaling
撕裂先天免疫信号传导中的蛋白质
基本信息
- 批准号:9385737
- 负责人:
- 金额:$ 41.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-12-15 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AGFG1 geneAdaptor Signaling ProteinAddressAntiviral AgentsApoptosisCaspaseCell DeathCell Death Signaling ProcessCell LineCellsCessation of lifeComplexDNADNA DamageDNA VirusesDataDeath DomainDefense MechanismsEngineeringFamilyFundingGenesGoalsHost DefenseHumanIRF3 geneImmuneImmune responseImmune signalingImmunityImpairmentIn VitroInfectionInflammationInflammatoryInflammatory ResponseInjuryInnate Immune ResponseInterferon Type IInterferonsLaboratoriesLigationLinkMediatingMitogen-Activated Protein KinasesModelingMolecularMusMutationNatural ImmunityNeonatalNucleic AcidsPathway interactionsPatternPattern recognition receptorPerinatal mortality demographicsPhosphorylationPhosphotransferasesPoly I-CPolyubiquitinationProductionProtein-Serine-Threonine KinasesProteinsPublishingRIPK1 geneRNARNA VirusesReactive Oxygen SpeciesReceptor SignalingRoleSignal PathwaySignal TransductionSmall Interfering RNASterilitySting InjurySystemTANK-binding kinase 1TLR3 geneTNF geneTestingTissuesToll-like receptorsTretinoinViralVirusVirus DiseasesVirus Replicationadaptive immune responseantiviral immunitybasecytokineds-DNAgenome-widehelicasein vivoinnovationkinase inhibitormacrophagemembermonocytenovelpublic health relevancereceptorrecruitresponsescaffoldsensortranscription factor
项目摘要
DESCRIPTION (provided by applicant): The death domain containing serine/threonine kinase Ripk1 is the core component of TNF-induced signaling complexes mediating NFκB and MAP kinase activation, apoptosis and an alternative form of caspase independent cell death called necroptosis. In unbiased genome wide siRNA screens for regulators of necroptosis, Ripk1, its deubiquitinase Cyld, the related Ripk3 as well as other proteins belonging to the interferon and Toll-like receptor signaling systems were identified. These studies and those using an allosteric Ripk1 kinase inhibitor or Ripk3-deficient mice establish necroptosis as a prominent host defense against viral infection. Necroptosis requires the kinase activities of Ripk1 and Ripk3 but precisely how Rip kinases initiate and execute necroptotic cell death is unknown. We have shown that Ripk1 has additional signaling functions beyond TNF, in nucleic acid sensing pathways mediated by TLR3 and Rig-I. Our preliminary studies additionally implicate Ripk1 in a cytosolic DNA sensing pathway involving Sting, Tbk1 and Irf3. Collectively, these studies predict a central role for Ripk1 in innate anti-viral immunity, however the perinatal lethality associated with a Ripk1-deficiency has precluded in vivo analyses. Goals of the current proposal are to test a requirement for Ripk1 in the anti-viral innate immune response using the conditional Ripk1 mice we have generated. We have also introduced a mutation into the Ripk1 locus that impairs the kinase activity of Ripk1. Our preliminary studies in Ripk1 kinase inactive MEFs and macrophages find these cells protected from TNF- and TLR3-induced necroptosis, respectively. An additional objective of this proposal is to examine the contribution of viral-initiated necroptosis to host defense in these newly engineered Ripk1 kinase inactive mice. In addition to virus-induced injury and inflammation, Rip kinases respond to non-microbial signals called danger-associated molecular patterns (DAMPs) released upon tissue injury. The long-term goal of these studies is to selectively inhibit Rip kinases in sterile inflammation without impairing innate immunity.
描述(由申请人提供):含丝氨酸/苏氨酸激酶Ripk 1的死亡结构域是TNF诱导的信号复合物的核心组分,介导NFκB和MAP激酶活化、细胞凋亡和另一种形式的半胱天冬酶非依赖性细胞死亡(称为坏死性凋亡)。在对坏死性凋亡调节因子的无偏基因组范围siRNA筛选中,鉴定了Ripk 1、其去泛素化酶Cyld、相关Ripk 3以及属于干扰素和Toll样受体信号传导系统的其他蛋白质。这些研究和使用变构Ripk 1激酶抑制剂或Ripk 3缺陷小鼠的研究确立了坏死性凋亡作为针对病毒感染的突出宿主防御。坏死性凋亡需要Ripk 1和Ripk 3的激酶活性,但Rip激酶如何启动和执行坏死性细胞死亡尚不清楚。我们已经表明,Ripk 1在TLR 3和Rig-I介导的核酸传感途径中具有TNF以外的额外信号传导功能。我们的初步研究还涉及Ripk 1在涉及斯汀,Tbk 1和Irf 3的细胞溶质DNA传感途径。总的来说,这些研究预测了Ripk 1在先天性抗病毒免疫中的核心作用,然而与Ripk 1缺陷相关的围产期致死性排除了体内分析。当前提案的目标是使用我们产生的条件性Ripk 1小鼠测试抗病毒先天免疫应答中对Ripk 1的需求。我们还在Ripk 1基因座中引入了一个突变,该突变会损害Ripk 1的激酶活性。我们对Ripk 1激酶失活的MEFs和巨噬细胞的初步研究发现,这些细胞分别受到TNF和TLR 3诱导的坏死性凋亡的保护。本提案的另一个目的是检查病毒引发的坏死性凋亡对这些新工程化的Ripk 1激酶失活小鼠的宿主防御的贡献。除了病毒诱导的损伤和炎症外,Rip激酶还对组织损伤时释放的称为细胞相关分子模式(DAMP)的非微生物信号做出反应。这些研究的长期目标是选择性抑制无菌炎症中的Rip激酶,而不损害先天免疫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHELLE ALICE KELLIHER其他文献
MICHELLE ALICE KELLIHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHELLE ALICE KELLIHER', 18)}}的其他基金
Role of EZH2 as a Driver and Therapeutic Target of Hepatocellular Carcinoma
EZH2 作为肝细胞癌驱动因素和治疗靶点的作用
- 批准号:
10587023 - 财政年份:2023
- 资助金额:
$ 41.88万 - 项目类别:
Transcriptional Upregulation of the Epigenetically Repressed FXN Gene as a Therapeutic Approach for Friedreich Ataxia
表观遗传抑制 FXN 基因的转录上调作为弗里德赖希共济失调的治疗方法
- 批准号:
10650343 - 财政年份:2019
- 资助金额:
$ 41.88万 - 项目类别:
Transcriptional Upregulation of the Epigenetically Repressed FXN Gene as a Therapeutic Approach for Friedreich Ataxia
表观遗传抑制 FXN 基因的转录上调作为弗里德赖希共济失调的治疗方法
- 批准号:
10433871 - 财政年份:2019
- 资助金额:
$ 41.88万 - 项目类别:
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
HCC 中一种新的可药物化表观遗传脆弱性途径
- 批准号:
10374806 - 财政年份:2018
- 资助金额:
$ 41.88万 - 项目类别: